Clincal Hospital Centre Rijeka

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Schizophrenia1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Boehringer Ingelheim2 trials

Closed trials

• Completed

  A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

  NCT05103657· Phase 2· Boehringer Ingelheim· Source

• Completed

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

  NCT04846881· Phase 3· Boehringer Ingelheim· Source